Entering text into the input field will update the search result below

Premarket analyst action - healthcare

Aug. 29, 2018 8:48 AM ETDova Pharmaceuticals, Inc. (DOVA) StockASRT, DOVA, DCPHBy: Douglas W. House, SA News Editor
  • Dova Pharmaceuticals (NASDAQ:DOVA) initiated with Outperform rating and $44 (79% upside) price target at Raymond James. Shares up 6% premarket.
  • Deciphera Pharmaceuticals (NASDAQ:DCPH) initiated with Outperform rating and $47 (33% upside) price target at Raymond James.
  • Assertio Therapeutics (NASDAQ:ASRT) downgraded to Neutral at Janney. Shares down 15% premarket after settling Oxycontin patent dispute with Purdue Pharma.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
DOVA--
Dova Pharmaceuticals, Inc.